caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1811169972

Stacey Parker-BrueggemannM.D.

Hematology-OncologyColorado Springs, COI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Stacey Parker-Brueggemann's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 35 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
JENNIE EDMUNDSON MEMORIAL HOSPITAL1951,980
CASS COUNTY MEMORIAL HOSPITAL911,663
SHENANDOAH MEDICAL CENTER642,439
CLARINDA REGIONAL HEALTH CENTER531,193
Christopher Koch
Diagnostic Radiology · Nashville, TN
40173
MANASIL, CHERYLE40129
BLEICHER, JON38145
Jean Thomsen
Pathology · Council Bluffs, IA
37118
Becki Goldberg-Kahn
Pathology · Council Bluffs, IA
37125
Jeremy Baum
Diagnostic Radiology · Papillion, NE
35159
Rajkumar Yarlagadda
Diagnostic Radiology · Omaha, NE
35142
Kelli Woltemath
General Practice · Hamburg, IA
34480
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
330
Unique beneficiaries
—
Total services
539
Distinct HCPCS
6
Medicare payment
$46K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 118 Hematology-Oncology providers in CO — below median (cohort median 956).
PRESCRIBING · PART D · 2024
Total Rx claims
339
Beneficiaries
—
Total drug cost
$207K
Distinct drugs
11
Brand share
61.7%
Top prescribed drugs
Apixaban114 claims
Rivaroxaban59 claims
Valacyclovir Hcl36 claims
Prednisone22 claims
Ondansetron Hcl21 claims
QUALITY · MIPS · 2024
Final MIPS score
86.0
Quality
78.6
Cost
74.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.46%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$211
Payment records
9
By payment type
Food and Beverage$211